Interventional device for percutaneous closure of atrial septal defects in pediatric and adult patients. Offers minimally invasive alternative to surgical repair for congenital heart conditions.
Manufactured by
Beijing Balance Medical Technology Co.,Ltd
China
Beijing Balance Medical Technology Co., Ltd., established in 2005, specializes in animal-derived implantable medical devices. The company has 13 Class III medical device registrations and over 20 domestic and international invention patents. Listed on the Shanghai Stock Exchange STAR Market (688198) in 2019, the company focuses on three main areas: surgical soft tissue repair, heart valve replacement and repair, and congenital heart disease interventional treatment.
© 2026 Suplivia · Home · Browse Products